- Report
- February 2024
- 100 Pages
Asia Pacific
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 80 Pages
Europe
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 80 Pages
North America
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 100 Pages
Global
From €4214EUR$4,750USD£3,670GBP
- Report
- February 2024
- 80 Pages
Europe
From €4214EUR$4,750USD£3,670GBP
- Report
- August 2023
- 150 Pages
North America
From €4214EUR$4,750USD£3,670GBP
- Report
- August 2023
- 90 Pages
Global
From €4214EUR$4,750USD£3,670GBP
- Report
- August 2023
- 110 Pages
Global
From €4214EUR$4,750USD£3,670GBP
- Report
- August 2023
- 80 Pages
Africa, Middle East
From €4214EUR$4,750USD£3,670GBP
- Report
- August 2023
- 75 Pages
North America
From €4214EUR$4,750USD£3,670GBP
- Report
- April 2023
- 110 Pages
Global
From €4214EUR$4,750USD£3,670GBP
- Report
- April 2023
- 115 Pages
Global
From €4214EUR$4,750USD£3,670GBP
- Report
- October 2022
- 70 Pages
Africa
From €4214EUR$4,750USD£3,670GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£966GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3327EUR$3,750USD£2,897GBP
- Report
- July 2024
- 100 Pages
Global
From €3327EUR$3,750USD£2,897GBP
- Report
- May 2023
- 116 Pages
Global
From €3992EUR$4,500USD£3,476GBP
- Report
- July 2024
- 139 Pages
Global
From €2218EUR$2,500USD£1,931GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2218EUR$2,500USD£1,931GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more